Show simple item record

dc.contributor.authorJordan, AN
dc.contributor.authorAnning, C
dc.contributor.authorWilkes, L
dc.contributor.authorBall, C
dc.contributor.authorPamphilon, N
dc.contributor.authorClark, CE
dc.contributor.authorBellenger, NG
dc.contributor.authorShore, AC
dc.contributor.authorSharp, ASP
dc.contributor.authorValderas, JM
dc.date.accessioned2022-06-22T13:00:51Z
dc.date.issued2022-03-04
dc.date.updated2022-06-21T21:29:40Z
dc.description.abstractBACKGROUND: Hypertension is a highly prevalent condition, with optimal treatment to BP targets conferring significant gains in terms of cardiovascular outcomes. Understanding why some patients do not achieve BP targets would be enhanced through greater understanding of their health-related quality of life (HRQoL). However, the only English language disease-specific instruments for measurement of HRQoL in hypertension have not been validated in accordance with accepted standards. It is proposed that the Spanish MINICHAL instrument for the assessment of HRQoL in hypertension could be translated, adapted and validated for use in the United Kingdom. The aim of the study was therefore to complete this process. METHODS: The MINICHAL authors were contacted and the original instrument obtained. This was then translated into English by two independent English-speakers, with these versions then reconciled, before back-translation and subsequent production of a 2nd reconciled version. Thereafter, a final version was produced after cognitive debriefing, for administration and psychometric analysis in the target population of patients living in the Exeter area (Southwest UK) aged 18-80 years with treatment-naïve grade II-III hypertension, before, during and after 18 weeks' intensive treatment. RESULTS: The English-language instrument was administered to 30 individuals (median age: 58.5 years, 53% male). Psychometric analysis demonstrated a floor effect, though no ceiling effect. Internal consistency for both state of mind (StM) and somatic manifestations (SM) dimensions of the instrument were acceptable (Cronbach's alpha = 0.81 and 0.75), as was test-retest reliability (ICC = 0.717 and 0.961) and construct validity, which was measured through co-administration with the EQ-5D-5L and Bulpitt-Fletcher instruments. No significant associations were found between scores and patient characteristics known to affect HRQoL. The EQ-5D-5L instrument found an improvement in HRQoL following treatment, with the StM and SM dimensions of the English language MINICHAL trending to support this (d = 0.32 and 0.02 respectively). CONCLUSIONS: The present study details the successful English translation and validation of the MINICHAL instrument for use in individuals with hypertension. The data reported also supports an improvement in HRQoL with rapid treatment of grade II-III hypertension, a strategy which has been recommended by contemporaneous European guidelines. Trial registration ISRCTN registry number: 57475376 (assigned 25/06/2015).en_GB
dc.description.sponsorshipNational Institute for Health Researchen_GB
dc.description.sponsorshipGawthorn Cardiac Trusten_GB
dc.format.extent39-
dc.format.mediumElectronic
dc.identifier.citationVol. 20, article 39en_GB
dc.identifier.doihttps://doi.org/10.1186/s12955-022-01943-9
dc.identifier.urihttp://hdl.handle.net/10871/130022
dc.identifierORCID: 0000-0002-7526-3038 (Clark, Christopher E)
dc.identifierScopusID: 56919048700 (Clark, Christopher E)
dc.language.isoenen_GB
dc.publisherBMCen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/35246164en_GB
dc.rights© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.en_GB
dc.subjectAdaptationen_GB
dc.subjectHypertensionen_GB
dc.subjectMINICHALen_GB
dc.subjectValidationen_GB
dc.titleCross-cultural adaptation of the Spanish MINICHAL instrument into English for use in the United Kingdom.en_GB
dc.typeArticleen_GB
dc.date.available2022-06-22T13:00:51Z
dc.identifier.issn1477-7525
exeter.article-number39
exeter.place-of-publicationEngland
dc.descriptionThis is the final version. Available from BMC via the DOI in this record. en_GB
dc.descriptionAvailability of data and materials: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.en_GB
dc.identifier.journalHealth and Quality of Life Outcomesen_GB
dc.relation.ispartofHealth Qual Life Outcomes, 20(1)
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2022-02-20
dc.rights.licenseCC BY
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2022-03-04
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-06-22T12:57:39Z
refterms.versionFCDVoR
refterms.dateFOA2025-03-06T23:19:32Z
refterms.panelAen_GB
refterms.dateFirstOnline2022-03-04


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco
mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Except where otherwise noted, this item's licence is described as © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.